5-phenylthiazole derivatives and their use as P13 kinase inhibitors

Details for Australian Patent Application No. 2004218239 (hide)

International Classifications

Event Publications

15 September 2005 PCT application entered the National Phase

PCT publication WO2004/078754 Priority application(s): WO2004/078754

22 February 2007 Application Accepted

Published as AU-B-2004218239

21 June 2007 Standard Patent Sealed

22 May 2008 Section 223 Application Received

Novartis AG An application to extend the time from 28 Feb 2006 to 28 Jul 2007 in which to file search results has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2006

10 July 2008 Section 223 Application Allowed

Novartis AG The time in which to file search results has been extended to 28 Jul 2007. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.